Style | Citing Format |
---|---|
MLA | Varshosaz J, et al.. "Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis." RSC Advances, vol. 6, no. 15, 2016, pp. 12337-12347. |
APA | Varshosaz J, Javanmard SH, Soghrati S, Behdadfar B (2016). Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis. RSC Advances, 6(15), 12337-12347. |
Chicago | Varshosaz J, Javanmard SH, Soghrati S, Behdadfar B. "Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis." RSC Advances 6, no. 15 (2016): 12337-12347. |
Harvard | Varshosaz J et al. (2016) 'Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis', RSC Advances, 6(15), pp. 12337-12347. |
Vancouver | Varshosaz J, Javanmard SH, Soghrati S, Behdadfar B. Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis. RSC Advances. 2016;6(15):12337-12347. |
BibTex | @article{ author = {Varshosaz J and Javanmard SH and Soghrati S and Behdadfar B}, title = {Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis}, journal = {RSC Advances}, volume = {6}, number = {15}, pages = {12337-12347}, year = {2016} } |
RIS | TY - JOUR AU - Varshosaz J AU - Javanmard SH AU - Soghrati S AU - Behdadfar B TI - Magnetic Chondroitin Targeted Nanoparticles for Dual Targeting of Montelukast in Prevention of In-Stent Restenosis JO - RSC Advances VL - 6 IS - 15 SP - 12337 EP - 12347 PY - 2016 ER - |